1 Preface.- 2 Epidemiology -- US, European, and global perspectives
unstable angina, NSTEMI, STEMI.- 3 Diagnosis -- symptoms, biomarkers, ECG.- 4 Risk stratification -- TIMI risk score, GRACE risk score, CRUSADE/PURSUIT risk score.- 5 Medical therapy -- antithrombotics, statins, etc.- 6 Percutaneous therapy -- culprit vessel versus mulitvessel
BMS vs DES.- 7 Surgical therapy.- 8 Prognosis. - 9 Controversies -- optimal antithrombotic strategy, fibrinolysis versus primary PCI for STEMI, preferred mode of revascularization (bare metal stents versus drug eluting stents versus CABG). - 10 Future approaches -- CT angio and other evolving imaging modalities, biomarkers, proteomics, genomics, angiogenesis, myogenesis. Appendix A -- Practice Guidelines -- ACC/AHA and ESC.- Appendix B -- Synopsis of Key Trials